NIFTY 50 Close 29 Oct

Q3 FY26 earnings results

Oct–Dec 2025 quarter · revenue and profit against the same quarter last year (YoY) and the quarter before (QoQ). INR crore, consolidated where filed.

377 companies have reported Oct–Dec 2025 and 936 more have a results date ahead. 63% grew profit from a year ago; the typical company's sales grew +12.3% and profit +10.1%. Strongest sector: Oil Gas & Consumable Fuels (+57.7%); weakest: Construction Materials (-8.4%).

Declared
377/ 1313
29% of scheduled reporters
Profit breadth
63%/37%
grew / declined · 335 comparable
Median sales growth
+12.3%
year on year, all reporters
Median profit growth
+10.1%
year on year, all reporters
Operating margin
185/184
expanded / shrank vs a year ago
Strongest / weakest

Oil Gas & Consumable Fuels +57.7%

Construction Materials -8.4%

median profit growth, 5+ reporters
1–9 of 9
CompanyRevenue (₹ Cr)Net profit (₹ Cr)Per shareQuarter
SymbolSectorReportedYoYQoQReportedYoYQoQEPS (₹)Verdict8Q profit
DRREDDYDr. Reddy's Laboratories LimitedHealthcare8,753+4.4%-0.8%1,190-15.2%-11.0%14.50MixedQ1 FY25 1,392 · Q2 FY25 1,342 · Q3 FY25 1,404 · Q4 FY25 1,587 · Q1 FY26 1,410 · Q2 FY26 1,337 · Q3 FY26 1,190
CIPLACipla LimitedHealthcare7,0740.0%-6.8%674-57.2%-50.2%8.37MixedQ1 FY25 1,175 · Q2 FY25 1,305 · Q3 FY25 1,575 · Q4 FY25 1,214 · Q1 FY26 1,292 · Q2 FY26 1,353 · Q3 FY26 674
MANKINDMankind Pharma LimitedHealthcare3,567+11.5%-3.5%414+7.5%-20.4%9.90GrowingQ1 FY25 543 · Q2 FY25 659 · Q3 FY25 385 · Q4 FY25 425 · Q1 FY26 445 · Q2 FY26 520 · Q3 FY26 414
TORNTPHARMTorrent Pharmaceuticals LimitedHealthcare3,303+17.6%0.0%635+26.2%+7.4%18.76GrowingQ1 FY25 457 · Q2 FY25 453 · Q3 FY25 503 · Q4 FY25 498 · Q1 FY26 548 · Q2 FY26 591 · Q3 FY26 635
SYNGENESyngene International LimitedHealthcare917-2.9%+0.7%15-88.5%-77.6%0.37ShrinkingQ1 FY25 76 · Q2 FY25 106 · Q3 FY25 131 · Q4 FY25 183 · Q1 FY26 87 · Q2 FY26 67 · Q3 FY26 15
ERISEris Lifesciences LimitedHealthcare807+11.0%+1.9%109+25.3%-18.7%7.32GrowingQ1 FY25 90 · Q2 FY25 96 · Q3 FY25 87 · Q4 FY25 102 · Q1 FY26 125 · Q2 FY26 134 · Q3 FY26 109
ACUTAASAcutaas Chemicals LimitedHealthcare393+42.9%+28.4%106+135.6%+47.2%13.19GrowingQ1 FY25 15 · Q2 FY25 38 · Q3 FY25 45 · Q4 FY25 63 · Q1 FY26 44 · Q2 FY26 72 · Q3 FY26 106
ONESOURCEOnesource Specialty Pharma LimitedHealthcare290-26.2%-22.9%-89n/a-990.0%-7.74LossQ1 FY25 -6 · Q2 FY25 -42 · Q3 FY25 -69 · Q4 FY25 98 · Q1 FY26 0 · Q2 FY26 10 · Q3 FY26 -89
CONCORDBIOConcord Biotech LimitedHealthcare278+13.9%+12.6%68-8.1%+7.9%6.48MixedQ1 FY25 58 · Q2 FY25 99 · Q3 FY25 74 · Q4 FY25 142 · Q1 FY26 43 · Q2 FY26 63 · Q3 FY26 68

Verdict: Growing sales and profit both up on a year ago · Shrinking both down · Mixed one up, one down · Back to profit a profit after a loss a year ago · Loss a loss this quarter. "n/a" means a year-ago or previous figure isn't available, or it was a loss, so a percentage would mislead.